Navigate Fool.com
Will VRX beat
the market?
Community Rating: 3 Stars: Appealing

122.05 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $121.39
Previous Close $122.05
Daily Range $120.02 - $123.57
52-Week Range $71.97 - $153.10
Market Cap $40.9B
P/E Ratio -45.20
Dividend (Yield) $0.00 (0.0%)
Volume 1,358,672
Average Daily Volume 2,329,192
Current FY EPS $2.96

How do you think VRX
will perform against the market?

Top VRX Bull/Bear Pitches


crimfunk (< 20)
Submitted February 2, 2008

undervalued, EPS 5 Year Growth (%) 199.82

0 Replies Reply Report this Post

tenmiles (< 20)
Submitted August 22, 2008

Technically ripe for 10-15% retracement from current $20.32 level; fundies aren't so hot either - seller here

0 Replies Reply Report this Post

News & Commentary

Is This the Time to Buy Pharma Stocks?

Is now the right time to get in on pharmaceutical stocks?

Is There Opportunity in the Eye-Care Sector?

Eye care companies like Essilor, Luxottica, and Cooper Companies offer good exposure to emerging-market growth and less regulatory and reimbursement risk.

Will Shire PLC Build Or Buy Its Future?

Shire may have to go back to M&A to deploy cash flow and augment a weak pipeline

Wednesday 3/26 Insider Buying Report: SANW, VRX

3 Reasons the Bears Are Wrong About Valeant Pharmaceuticals

These respected contrarian investors may still have a few holes in their bearish arguments.

Is Now a Good Time to Sell Anacor Pharmaceuticals, Inc.?

Anacor Pharmaceuticals has been one of the hottest biotechs over the past year. Can it continue to move upward?

3 Prescription Drugs You Didn't Know Come From Marijuana

A close look at three prescription drugs you probably didn't know come from one of the world's most controversial plants: cannabis.

Can Valeant Continue This Growth?

Valeant hasn't sated its appetite for deals yet, and cornerstone positions in dermatology and eye care offer meaningful long-term moats.

Biotech Stocks to Buy After the Pullback

Can Allergan's Growth Continue?

Allergan offers uncommon growth for a large-cap drug company.

See More VRX News...





Valeant Pharmaceuticals (VRX) Description

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology. Website: http://www.valeant.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks